PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
63 hedge funds and large institutions have $184M invested in PLx Pharma Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 5 closing their positions.
340% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 5
333% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 6
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
59% more capital invested
Capital invested by funds: $116M → $184M (+$68M)
37% more funds holding
Funds holding: 46 → 63 (+17)
23% more call options, than puts
Call options by funds: $7.56M | Put options by funds: $6.14M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.45M |
| 2 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$3.38M |
| 3 |
BlackRock
New York
|
+$3.03M |
| 4 |
Jane Street
New York
|
+$3M |
| 5 |
Two Sigma Investments
New York
|
+$2.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$6.25M |
| 2 |
MS
Maven Securities
St Helier,
Jersey
|
-$5.24M |
| 3 |
Renaissance Technologies
New York
|
-$2.88M |
| 4 |
AGM
Alpine Global Management
New York
|
-$1.08M |
| 5 |
PA
Perceptive Advisors
New York
|
-$793K |
PLXP Hedge Fund Activity: Q3 2021 in Review
63 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q3 2021, worth a combined $184M — up 59% from $116M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new PLXP positions and 5 closed out — a net gain of 17 holders — while 26 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.45M. The largest seller was Marshall Wace, cutting an estimated $6.25M.
- 63 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q3 2021, up from 46 in Q2 2021.
- Funds reported $184M of PLx Pharma Inc. Common Stock stock for Q3 2021, up 59% quarter-over-quarter.
- 22 funds opened new PLx Pharma Inc. Common Stock positions in Q3 2021 and 5 closed out, a net change of +17 holders.
- The largest PLx Pharma Inc. Common Stock buyer in Q3 2021 was Vanguard Group, an estimated $3.45M added.
- The largest PLx Pharma Inc. Common Stock seller in Q3 2021 was Marshall Wace, an estimated $6.25M sold.
Based on aggregated 13F filings for Q3 2021.